San Diego, CA, United States of America

Stefan McCarver

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 6.3

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Princeton, NJ (US) (2021 - 2024)
  • San Diego, CA (US) (2023 - 2024)

Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: The Innovative Journey of Stefan McCarver

Introduction

Stefan McCarver is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of IL-17 inhibitor compounds. With a total of 7 patents to his name, McCarver's work is recognized for its potential impact on treating various disorders.

Latest Patents

Among his latest patents, McCarver has developed Imidazopyridazine IL-17 inhibitor compounds. These patents disclose compounds that are designed to treat or ameliorate IL-17 mediated syndromes, disorders, and diseases. The compounds are defined by specific formulas and include pharmaceutically acceptable salts, showcasing McCarver's innovative approach to pharmaceutical development.

Career Highlights

Throughout his career, McCarver has worked with notable organizations such as Janssen Pharmaceutica and Princeton University. His experience in these esteemed institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of McCarver's notable coworkers include Steven D. Goldberg and Steven P. Meduna. Their collaborative efforts have further advanced the research and development of innovative pharmaceutical solutions.

Conclusion

Stefan McCarver's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in treating IL-17 mediated conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…